CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to obtain data from hospitalized Community Acquired Pneumonia (CAP)
patients on the disease including disease severity, clinical signs and symptoms and measures
used for diagnosis in daily routine practice as well as data on Avelox® including information
on the use, effectiveness, treatment outcome, safety and tolerability.
As this is a non-interventional observational study, routine clinical practice is observed.
The application of medications follows the normal routines and is decided by the treating
physician under recognition of the package insert.
Details
Lead Sponsor:
Bayer
Treatments:
Moxifloxacin Norgestimate, ethinyl estradiol drug combination